Highlights of the important and interesting in the world of healthcare:
Tattletale medicine? Novartis AG plans to seek regulatory approval within 18 months for a pioneering tablet containing an embedded microchip that sends information to your doctor about whether you took your medication and how it’s working, according to Reuters.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Post-election quarterbacking. If a Republican “defunding” fight over appropriations leads to political gridlock in Washington, we might just see healthcare as the preeminent 2012 issue — a vote for Republicans would mean repeal it, and a vote for Democrats would mean implement it, writes The Health Care Blog.
When is a biotech not small? When it’s controlled or affiliated with a privately run conglomerate. As a result, Siga Technologies might lose a $2.8 billion contract with the Department of Health & Human Services to develop a drug to treat smallpox, writes the Pharmalot blog.
FDA risked integrity? A congressional committee plans to release a report by the Government Accountability Office today that says the FDA risked giving the appearance it had compromised its integrity by awarding Momenta Pharmaceuticals Inc. in Boston first right to sell the generic version of the blood thinner Lovenox in July, reports the Wall Street Journal.
Wanted: social media manager. As hospitals continue to build their online media presence, more of them are hiring dedicated social media managers to deal with legal and ethical guidelines, as well as to train physicians to use the tools, American Medical News reports.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Medtronic hearts iPads. Medtronic Inc.’s chief information officer, Michael Hedges, has bought 4,500 iPads since April, mostly to show off his company’s product information to customers, reports Computerworld.
